Home
Conditions
Urologic Neoplasms

Clinical trial condition

Urologic Neoplasms

Explore clinical trials studying Urologic Neoplasms. Study availability and eligibility vary by location and protocol.

2,952 public trials 630 recruiting studies

Refine in advanced search Browse all conditions

Urologic Neoplasms trial results

Completed

MS-275 in Treating Patients With Advanced Solid Tumors or Lymphoma

NCT00020579

Conditions: AIDS-related Kaposi sarcoma, Adenocarcinoma, Adenoma, +214 more
Locations: National Naval Medical Center Bethesda, Maryland, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

NCI - Center for Cancer Research Bethesda, Maryland, United States

View Trial Details

Completed

Ixabepilone in Treating Young Patients With Solid Tumors or Leukemia That Haven't Responded to Therapy

NCT00030108

Conditions: Adnexal Diseases, Astrocytoma, Bone Marrow Diseases, +92 more
Locations: Children's National Medical Center Washington D.C., District of Columbia, United States

Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Positron Emission Tomography and CT Scan in Predicting Response in Patients With Metastatic Melanoma or Kidney Cancer Who Are Undergoing Cellular Adoptive Immunotherapy on a Surgery Branch Clinical Trial

NCT00316901

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +24 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Genetic Study to Identify Gene Mutations in Participants Previously Enrolled in Clinical Trial NCI-99-C-0053 Who Have Von Hippel-Lindau Syndrome or Are at Risk for Von Hippel-Lindau Syndrome

NCT00075348

Conditions: Abnormalities, Multiple, Adenocarcinoma, Angiomatosis, +26 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Trials Referral Office Bethesda, Maryland, United States

View Trial Details

Completed

Monoclonal Antibody Therapy in Treating Patients With Metastatic Renal Cell Cancer

NCT00057889

Conditions: Adenocarcinoma, Carcinoma, Carcinoma, Renal Cell, +14 more
Locations: Warren Grant Magnuson Clinical Center - NCI Clinical Studies Support Bethesda, Maryland, United States

View Trial Details

Completed

Safety and Pharmacokinetic Study of EO9(Intravesical Instillation)

NCT01373398

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Site 01 Seoul, South Korea

Site 02 Seoul, South Korea

View Trial Details

Completed

Quality of Life and Symptom Management in Patients With Bladder Cancer

NCT00772018

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, Texas, United States

Veterans Affairs Medical Center - Houston Houston, Texas, United States

View Trial Details

Completed

Health-Related Quality of Life in Patients With Bladder Cancer

NCT00744744

Conditions: Bladder Cancer, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, +9 more
Locations: Dan L. Duncan Cancer Center at Baylor College of Medicine Houston, Texas, United States

View Trial Details

Completed

Safety and Tolerability Study of TAK-165 in Subjects With Tumors Expressing HER2

NCT00034281

Conditions: Adnexal Diseases, Breast Diseases, Breast Neoplasm, +46 more
Locations: Arizona Cancer Center Scottsdale, Arizona, United States

The Institute for Drug Development San Antonio, Texas, United States

Brooke Army Medical Center/Drug Development Unit San Antonio, Texas, United States

South Texas VA, Audie Murphy Division San Antonio, Texas, United States

View Trial Details

Completed

Study of Genexol-PM in Patients With Advanced Urothelial Cancer Previously Treated With Gemcitabine and Platinum

NCT01426126

Conditions: Bladder Cancer, Carcinoma, Carcinoma, Transitional Cell, +16 more
Locations: Asan Medical Center Seoul, South Korea

View Trial Details

Urologic Neoplasms

Urologic Neoplasms trial results

Related conditions